packageCilostazol

cilostazol

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Cilostazol is a platelet aggregation inhibitor used to treat intermittent claudication and cerebral infarction. It is an approved medicine, though it carries a boxed warning and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q258591 and the WHO ATC classification; not checked by a person.

name:cilostazol
ATC codes:B01AC23
DrugBank:DB01166
PubChem CID:2754
ChEBI:31401
Wikidata:Q258591
formula:C20H27N5O2
molar mass:369.469 g/mol (PubChem CID 2754)
logP:3.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown